Produkty 4373-41-5

CAS 4373-41-5 występuje w naszej ofercie pod nazwami: Maslinic Acid, Maslinic Acid, >95% (HPLC), Maslinic acid, 98%, Maslinic acid/ 99.16% (existing batch purity), Maslinic Acid, >98.0%(HPLC)(T). Oferty producentów: GLPBio, TRC, AmBeed, TargetMol, TCI. Dostępne opakowania: 5mg, 100mg, 50mg, 10mg, 25mg, 1mg, 250mg, 500mg.

Maslinic Acid
GLPBio
  • opakowanie: 5mg, 10mg, 25mg
  • Warianty: 3
od 625,12
Zobacz produkt
Maslinic Acid, >95% (HPLC)
TRC
  • opakowanie: 100mg, 50mg, 5mg
  • Warianty: 3
Zobacz produkt
Maslinic acid, 98%
AmBeed, Fluorochem
  • opakowanie: 50mg, 10mg, 25mg, 100mg
  • Warianty: 7
od 658,50
Zobacz produkt
Maslinic acid/ 99.16% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 386,15
Zobacz produkt
Maslinic Acid, >98.0%(HPLC)(T)
TCI
  • opakowanie: 100mg
  • Warianty: 1
od 1205,06
Zobacz produkt
Maslinic acid
Biosynth, HPC Standards
  • opakowanie: 50mg, 25mg, 100mg, 250mg
  • Warianty: 6
Zobacz produkt
Maslinic acid, 98.00%
Chemat
  • opakowanie: 25mg
  • Warianty: 1
od 2142,93
Zobacz produkt
Maslinic acid, 98%, 98%
Chemat
  • opakowanie: 100mg, 250mg, 1g, 1mg
  • Warianty: 4
od 122,00
Zobacz produkt
Maslinic acid, 99.87%
MedChemExpress
  • opakowanie: 25 mg, 10mM/1mL, 10 mg, 5 mg
  • Warianty: 4
od 551,89
Zobacz produkt
Maslinic acid (Standard)
MedChemExpress
  • opakowanie: 25 mg, 5 mg, 10 mg, 100 mg
  • Warianty: 5
od 1197,41
Zobacz produkt
Maslinic acid, min. 95 %, 25 mg
Roth
  • opakowanie: 25mg
  • Warianty: 1
od 1033,60
Zobacz produkt
Maslinic acid, min. 95 %, 50 mg
Roth
  • opakowanie: 50mg
  • Warianty: 1
od 1647,14
Zobacz produkt
Maslinic acid, min. 95 %, 100 mg
Roth
  • opakowanie: 100mg
  • Warianty: 1
od 2524,99
Zobacz produkt
Maslinic acid, min. 95 %, 250 mg
Roth
  • opakowanie: 250mg
  • Warianty: 1
od 3988,07
Zobacz produkt

(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid (CAS 4373-41-5) to związek chemiczny o wzorze sumarycznym C30H48O4 i masie molowej 472.7 g/mol. Nazwa systematyczna IUPAC: (4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid. InChIKey: MDZKJHQSJHYOHJ-LLICELPBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC30H48O4
Masa molowa472.7 g/mol
Nazwa IUPAC(4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
InChIKeyMDZKJHQSJHYOHJ-LLICELPBSA-N
SMILESC[C@@]12CC[C@@H]3[C@@]([C@H]1CC=C4[C@]2(CC[C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)C)(C[C@H]([C@@H](C3(C)C)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Maslinic acid, Crategolic acid, Crataegolic acid, Maslic acid, Masilinic acid, 2alpha-hydroxyoleanolic acid, 2alpha,3beta-dihydroxyurs-12-en-29-oic acid, 2-hydroxyoleanolic acid, Olean-12-en-28-oic acid, 2,3-dihydroxy-, (2alpha,3beta)-, (2alpha, 3beta)-2,3-dihydroxyolean-12-en-28-oic acid
Powiązane formy tego związku
(4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-10,11-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O4
Izomery (ten sam wzór sumaryczny)
(4aS,6aR,6aS,6bR,8aR,9R,10S,12aR,14bS)-10-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O4
(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R,5S,6R)-5,6,7-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-3-one C30H48O4
(5R,9R,10R,13S,14S,17S)-17-[(1R)-1-[(2R,3R,4S)-3,4-dihydroxy-5,5-dimethyloxolan-2-yl]ethyl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C30H48O4
(3S,4R,4aR,6aR,6bS,8R,8aS,14aR,14bS)-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-1,2,3,4a,5,6,7,8,9,10,12,14a-dodecahydropicene-3,8-diol C30H48O4
(1R,3aS,5aR,5bR,7aR,8R,9S,11aR,11bR,13aR,13bR)-9-hydroxy-8-(hydroxymethyl)-5a,5b,8,11a-tetramethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid C30H48O4
(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid C30H48O4
(1S,2R,4aS,6aR,6aS,6bR,8aR,10R,11R,12aR,14bS)-10,11-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid C30H48O4
(5R,9R,10R,13S,14S,17S)-17-[(3S,5R,6S)-5,6-dihydroxy-7,7-dimethyloxepan-3-yl]-4,4,10,13,14-pentamethyl-1,2,5,6,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-3-one C30H48O4
(1S,2S,4S,5R,8R,9R,10S,13S,14R,17S,18R)-9-(hydroxymethyl)-4,5,9,13,20,20-hexamethyl-24-oxahexacyclo[15.5.2.01,18.04,17.05,14.08,13]tetracos-15-ene-2,10-diol C30H48O4
(1R,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-1,10-dihydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O4
(4aR,5R,6aR,6aS,6bR,8aR,10S,12aR,14bS)-5,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid C30H48O4